Update on rescue therapies in patients with lamivudine-resistant chronic hepatitis B

Update on rescue therapies in patients with lamivudine-resistant chronic hepatitis B

Daniel C Chao, Ke-Qin HuDivision of Gastroenterology and Hepatology, University of California, Irvine Medical Center, Orange, CA, USAAbstract: Chronic hepatitis B continues to be a global problem, with an estimated 240 million cases according to the World Health Organization. Chronic infect...

Full description

Bibliographic Details
Main Authors:	Chao DC, Hu KQ
Format:	Article
Language:	English
Published:	Dove Medical Press 2013-08-01
Series:	Drug Design, Development and Therapy
Online Access:	http://www.dovepress.com/update-on-rescue-therapies-in-patients-with-lamivudine-resistant-chron-a14096

Similar Items

Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir
by: Hee-Jeong Jeon, et al.
Published: (2017-09-01)

Cost-effectiveness analysis of different rescue therapies in patients with lamivudine-resistant chronic hepatitis B in China
by: Wu Bin, et al.
Published: (2012-11-01)

Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus
by: Hyun Young Woo, et al.
Published: (2014-06-01)

Long-term outcomes of two rescue therapies in lamivudine-refractory patients with chronic hepatitis B: combined lamivudine and adefovir, and 1-mg entecavir
by: EunYoung Ze, et al.
Published: (2014-09-01)

Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B
by: Chan Ho Park, et al.
Published: (2016-03-01)

Successful lamivudine therapy for chronic hepatitis B in the family
by: Nožić Darko
Published: (2006-01-01)

Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients
by: Jeong Han Kim, et al.
Published: (2013-09-01)

Lamivudine therapy in HBeAg negative chronic hepatitis B patients
by: E. Guclu, et al.
Published: (2014-04-01)

Tenofovir as Rescue Therapy Following Clinical Failure to Lamivudine in Severe Acute Hepatitis B
by: Jurgen Gerada, et al.
Published: (2013-06-01)

Acute pancreatitis associated with lamivudine therapy for chronic B hepatitis
by: Felipe Francisco Tuon, et al.

Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis
by: Hu Peng, et al.
Published: (2011-08-01)

Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B
by: Jeong Han Kim, et al.
Published: (2014-09-01)

Predictive value of HBcrAg for lamivudine resistance in patients with chronic hepatitis B
by: LIU Cheng
Published: (2013-11-01)

Meta-analysis: Adefovir dipivoxil in combination with lamivudine in patients with lamivudine-resistant hepatitis B virus
by: Wang Li-Chun, et al.
Published: (2009-10-01)

Lamivudine therapy for chronic hepatitis B in children: a meta-analysis
by: Aoran Luo, et al.
Published: (2019-07-01)

Antiviral Therapy in Lamivudine-Resistant Chronic Hepatitis B Patients: A Systematic Review and Network Meta-Analysis
by: Hui-Lian Wang, et al.
Published: (2016-01-01)

Lamivudine therapy for hepatitis B in renal transplantation
by: F.R.L. Santos, et al.
Published: (2002-02-01)

Efficacy and safety on tenofovire therapy in patients with hepatitis B viral infections resistent to lamivudin
by: Katanić N., et al.
Published: (2015-01-01)

Lamivudine for chronic hepatitis B: a brief review
by: Emilio Palumbo

Treatment of chronic hepatitis B in Oman experience with lamivudine
by: Upadhyay Dip Amal, et al.
Published: (2003-01-01)

The efficacy of lamivudine in the treatment of reactivation of chronic hepatitis B virus infection in patients on immunosuppressive therapy
by: Delić Dragan, et al.
Published: (2011-01-01)

Clinical study of lamivudine and Biejia Xiaozheng pill combination therapy for chronic hepatitis B
by: LUO Jianjun
Published: (2013-04-01)

Genotypes and resistance loci in patients with chronic hepatitis B achieving virologic breakthrough in treatment with lamivudine combined with adefovir after developing drug resistance in treatment with lamivudine alone
by: YANG Dongqiang, et al.
Published: (2016-03-01)

Impact of prior lamivudine use on the antiviral efficacy and development of resistance to entecavir in chronic hepatitis B patients
by: Joo An Hwang, et al.
Published: (2015-06-01)

Cost-effectiveness of telbivudine versus lamivudine for chronic hepatitis B
by: Astrid Wiens, et al.

Cost-effectiveness of telbivudine versus lamivudine for chronic hepatitis B
by: Astrid Wiens, M.Sc., et al.
Published: (2011-05-01)

Efficacy of Lamivudine or Entecavir on Acute Exacerbation of Chronic Hepatitis B
by: Tatsuo Kanda, Masami Shinozaki, Hidehiro Kamezaki, Shuang Wu, Shingo Nakamoto, Makoto Arai, Keiichi Fujiwara, Nobuaki Goto, Fumio Imazeki, Osamu Yokosuka
Published: (2012-01-01)

The relationship between Zheng and the effect of Lamivudine in chronic hepatitis B
by: Pei-Yun Lin, et al.
Published: (2005)

Cost-effectiveness Analysis of Lamivudine and EntecavirTreatment in Patients with Chronic Hepatitis B
by: Kai-Fang Chang, et al.
Published: (2013)

Lamivudine plus adefovir is a good option for chronic hepatitis B patients with viral relapse after cessation of lamivudine treatment
by: Zhang Yong, et al.
Published: (2011-08-01)

Mutation Pattern of Lamivudine Resistance in Relation to Hepatitis B Genotypes
by: Damerow, Hans
Published: (2012)

Antiviral therapy against chronic hepatitis B in Brazil: high rates of lamivudine resistance mutations and correlation with HBV genotypes
by: Francisco Campello do Amaral Mello, et al.
Published: (2012-05-01)

Genotypic Resistance Remains A Concern In Chronic Hepatitis B Patients With High Viral Load After Lamivudine And Adefovir Combination Therapy
by: Huang M, et al.
Published: (2019-10-01)

Clinical efficacy of combined treatment with entecavir and adefovir dipivoxil for lamivudine-resistant chronic hepatitis B
by: BAO Jun
Published: (2014-10-01)

Initial combining lamivudine and adefovir dipivoxil and lamivudine/entecavir monotherapy in hepatitis B e antigen-positive chronic hepatitis B with high viral load
by: J. You, et al.
Published: (2014-04-01)

Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis
by: Yang Jin, et al.
Published: (2009-05-01)

Lamivudine for the Treatment of Membranous Glomerulopathy Secondary to Chronic Hepatitis B Infection
by: SI Gan, et al.
Published: (2005-01-01)

The effects of prolonged Lamivudine administration as a sole treatment following the combination therapy of Interferon Alpha and Lamivudine in children for HBeAg (+) chronic hepatitis B
by: Sezin Asik Akman,1 Sabriye Cokceken Okcu,2 Sumer Sutcuoglu.2
Published: (2007-10-01)

Case report <br> Effective combination of lamivudine with ursodeoxycholic acid in the treatment of acute flare of chronic hepatitis B infection after discontinuation of lamivudine therapy
by: Krisztina Hagymási, et al.
Published: (2005-09-01)

Long-term outcomes of ongoing lamivudine treatment in chronic hepatitis B patients in Kocaeli
by: S.C. Akhan, et al.
Published: (2014-04-01)